Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Apoptosis is programmed cell death that occurs by several pathways. Caspase-3 is induced by active caspase-9 via the intrinsic pathway. The aim of this research was to explore the expression of caspase-3 and caspase-9 in schizophrenia patients and healthy samples. Methods: RNA was isolated from the peripheral blood of 39 schizophrenia patients’ and healthy samples. After cDNA synthesis, real time PCR (RT-PCR) was used to analyse caspase-3 and caspase-9 gene expression. The severity of psychopathological symptoms of schizophrenia was evaluated using the Positive and Negative Symptoms Scale for schizophrenia (PANSS) and Clinical Global Impressions (CGI). Results: The expression of caspase-3 and caspase-9 genes was higher in schizophrenia patients than in healthy samples (p = 0.012, p = 0.002, respectively). The increase in caspase-3 gene expression was significant with being male, smoking and with a duration of less than 6 years (p = 0.047, p = 0.049, p = 0.034, respectively). On the other hand, the increase in caspase-9 gene expression was significant in patients who is smoke, have children, and are under 33 years old (p = 0.040, p = 0.043, p = 0.045, respectively). A significant positive correlation was detected between the caspase-3 and caspase-9 gene expression (r = 0.3218, p = 0.049). Conclusion: Our findings indicate that caspase-3 and caspase-9 gene expression may activate cell death mechanisms by intrinsic apoptotic genes. Furthermore, caspase-3 and caspase-9 may play essential roles in different ways in schizophrenia. Hence there is a need to further study the apoptotic mechanism with expanded patient populations.
Abstract
Objective: Apoptosis is programmed cell death that occurs by several pathways. Caspase-3 is induced by active caspase-9 via the intrinsic pathway. The aim of this research was to explore the expression of caspase-3 and caspase-9 in schizophrenia patients and healthy samples. Methods: RNA was isolated from the peripheral blood of 39 schizophrenia patients’ and healthy samples. After cDNA synthesis, real time PCR (RT-PCR) was used to analyse caspase-3 and caspase-9 gene expression. The severity of psychopathological symptoms of schizophrenia was evaluated using the Positive and Negative Symptoms Scale for schizophrenia (PANSS) and Clinical Global Impressions (CGI). Results: The expression of caspase-3 and caspase-9 genes was higher in schizophrenia patients than in healthy samples (p = 0.012, p = 0.002, respectively). The increase in caspase-3 gene expression was significant with being male, smoking and with a duration of less than 6 years (p = 0.047, p = 0.049, p = 0.034, respectively). On the other hand, the increase in caspase-9 gene expression was significant in patients who is smoke, have children, and are under 33 years old (p = 0.040, p = 0.043, p = 0.045, respectively). A significant positive correlation was detected between the caspase-3 and caspase-9 gene expression (r = 0.3218, p = 0.049). Conclusion: Our findings indicate that caspase-3 and caspase-9 gene expression may activate cell death mechanisms by intrinsic apoptotic genes. Furthermore, caspase-3 and caspase-9 may play essential roles in different ways in schizophrenia. Hence there is a need to further study the apoptotic mechanism with expanded patient populations.
참고문헌 (38)
- Patel KR, "Schizophrenia : overview and treatment options", P T, 39, pp.638~645 (2014)
- Hu L, "Ulk4, a newly discovered susceptibility gene for schizophrenia, regulates corticogenesis in mice", Front Cell Dev Biol, 9, pp.645368~ (2021)
- Guillen-Aguinaga S, "Schizophrenia and hospital admissions for cardiovascular events in a large population : the APNA study", J Cardiovasc Dev Dis, 9, pp.25~ (2022)
- Bredesen DE, "Neural apoptosis", Ann Neurol, 38, pp.839~851 (1995)
- Su JH, "Bax protein expression is increased in Alzheimer’s brain : correlations with DNA damage, Bcl-2 expression, and brain pathology", J Neuropathol Exp Neurol, 56, pp.86~93 (1997)
- Jarskog LF, "Apoptotic mechanisms in the pathophysiology of schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.846~858 (2005)
- Gusev A, "Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights", Nat Genet, 50, pp.538~548 (2018)
- Föcking M, "Epigenetic factors in schizophrenia : mechanisms and experimental approaches", Mol Neuropsychiatry, 5, pp.6~12 (2019)
- Kerr JF, "Apoptosis : a basic biological phenomenon with wide-ranging implications in tissue kinetics", Br J Cancer, 26, pp.239~257 (1972)
- Paweletz N, "Walther Flemming : pioneer of mitosis research", Nat Rev Mol Cell Biol, 2, pp.72~75 (2001)
- Kerr JF, "History of the events leading to the formulation of the apoptosis concept", Toxicology, 181-182, pp.471~474 (2002)
- Zerban H, "Cell proliferation and cell death(apoptosis)in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability", Carcinogenesis, 15, pp.2467~2473 (1994)
- Evan G, "A matter of life and cell death", Science, 281, pp.1317~1322 (1998)
- McIlwain DR, "Caspase functions in cell death and disease", Cold Spring Harb Perspect Biol, 5, pp.a008656~ (2013)
- Henry-Mowatt J, "Role of mitochondrial membrane permeabilization in apoptosis and cancer", Oncogene, 23, pp.2850~2860 (2004)
- Zou H, "An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9", J Biol Chem, 274, pp.11549~11556 (1999)
- Marks N, "Activation of caspase-3and apoptosis in cerebellar granule cells", J Neurosci Res, 52, pp.334~341 (1998)
- Wiley SR, "Identification and characterization of a new member of the TNF family that induces apoptosis", Immunity, 3, pp.673~682 (1995)
- Falschlehner C, "TRAIL signalling : decisions between life and death", Int J Biochem Cell Biol, 39, pp.1462~1475 (2007)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders : DSM-5" (2013), American Psychiatric Association
- Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Mazarakis ND, "Apoptosis in neural development and disease", Arch Dis Child Fetal Neonatal Ed, 77, pp.F165~F170 (1997)
- Clay HB, "Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia", Int J Dev Neurosci, 29, pp.311~324 (2011)
- Yuan J, "Apoptosis in the nervous system", Nature, 407, pp.802~809 (2000)
- Yepes M, "TWEAK and the central nervous system", Mol Neurobiol, 35, pp.255~265 (2007)
- Kiliç F, "Serum tumor necrosis factorlike weak inducer of apoptosis levels are elevated in schizophrenia", Braz J Psychiatry, 43, pp.242~246 (2021)
- Beyazyüz M, "Increased serum levels of apoptosis in deficit syndrome schizophrenia patients : a preliminary study", Neuropsychiatr Dis Treat, 12, pp.1261~1268 (2016)
- Catts VS, "Apoptosis and schizophrenia : a pilot study based on dermal fibroblast cell lines", Schizophr Res, 84, pp.20~28 (2006)
- Szymona K, "Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia", Psychiatr Pol, 53, pp.1293~1303 (2019)
- López E, "Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat", Neuroscience, 91, pp.1461~1470 (1999)
- Hartmann A, "Caspase-3 : a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease", Proc Natl Acad Sci U S A, 97, pp.2875~2880 (2000)
- Oltvai ZN, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death", Cell, 74, pp.609~619 (1993)
- Jarskog LF, "Apoptotic proteins in the temporal cortex in schizophrenia : high Bax", Bcl-2ratio without caspase-3 activation, 2004, pp.161, 109~115
- Green DR, "Mitochondria and apoptosis", Science, 281, pp.1309~1312 (1998)
- Gu S, "Altered mRNA expression levels of autophagy-and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine", Neurosci Lett, 746, pp.135669~ (2021)
- Manzella F, "Smoking in schizophrenic patients : a critique of the self-medication hypothesis", World J Psychiatry, 5, pp.35~46 (2015)
- Buosi P, "Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients", Trends Psychiatry Psychother, 43, pp.278~285 (2021)
- Yu Q, "The relationship between endoplasmic reticulum stress and autophagy in apoptosis of BEAS-2B cells induced by cigarette smoke condensate", Toxicol Res(Camb), 10, pp.18~28 (2021)